Healio

First patient enrolled in enVista MX60EF trifocal IOL trial

Please provide your email address to receive an email when new articles are posted on . Bausch + Lomb has enrolled the first patient in a clinical trial of the enVista MX60EF trifocal IOL, according ...
Stockhouse

Bausch + Lomb Launches enVista Aspire(TM) Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire ...
Healio

VIDEO: First experience with new IOL technology shows numerous benefits

Please provide your email address to receive an email when new articles are posted on .
Nasdaq

Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the ...
Finanznachrichten

Bausch + Lomb Corporation: Bausch + Lomb Launches enVista Aspire Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

Bausch Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire ...